Levosimendan Intermediate CAS 36725-28-7 Maʻemaʻe >99.5% (HPLC) Hale Hana
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl-3(2H)-Pyridazinone (CAS: 36725-28-7) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Inoa Kimia | 6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl-3(2H)-Pyridazinone |
Nā huaʻōlelo like | 6-(p-Aminophenyl) -5-methyl-4,5-dihydro-3(2H) -pyridazinone;1,4-Dihydro-4-Methyl-3-(4-Aminophenyl)pyridazine-6(5H)-one ;ʻO ka haumia Levosimendan 5 |
Helu CAS | 36725-28-7 |
Helu CAT | RF-PI1976 |
Kūlana Kūʻai | Ma ka waihona, hoʻonui ʻia a hiki i nā tona |
ʻĀpana Molekala | C11H13N3O |
Kaumaha Molecular | 203.25 |
Lae hehee | 194.0 a i 198.0 ℃ |
ʻO ka mānoanoa | 1.30±0.10 g/cm3 |
Brand | Kemika Ruifu |
'ikamu | Nā kikoʻī |
Ka nana aku | ʻO ke keʻokeʻo a hiki i ka pauka waihoʻoluʻu ʻeleʻele |
ʻIkepili (HPLC) | ʻO ka HPLC RT o ke kiʻekiʻe nui e pili ana i ka hana maʻamau o ka hale |
Nalo ma ka maloo | <0.50% |
Koena ma ka Ignition | <0.20% |
Na mea pili | (HPLC) |
Hoʻokahi haumia | <0.20% |
Huina paumaele | <0.50% |
Maʻemaʻe / Kaʻina Hanana | >99.5% (HPLC) |
Nā Metala Kaumaha | <20ppm |
Proton NMR Spectrum | Kūlike i ka hoʻolālā |
Kūlana hoʻāʻo | Kūlana ʻoihana |
Hoʻohana | Kūwaena o Levosimendan (CAS: 141505-33-1) |
Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai
6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl-3(2H)-Pyridazinone (CAS: 36725-28-7) he mea waena o Levosimendan (CAS: 141505-33-1).Ua hoʻokomo ʻia ʻo Levosimendan ma Suedena ma ke ʻano he iv infusion no ka mālama ʻana i ka puʻuwai koʻikoʻi a i ʻole nā hōʻailona refractory o ka pau ʻole o ka naʻau i nā hihia i lawa ʻole ka mālama maʻamau (eg, diuretic a i ʻole ACE inhibitor).Hoʻoikaika pū ia i nā adenostne triphosphate-regulated ventricular a me arterial adenostne triphosphate e hoʻoulu ai i ka vasodilatation i ka ʻiʻo maʻemaʻe vascular a pale i ka myocardium mai ka infarction.ʻAʻole paha ke kuleana o kāna haʻahaʻa haʻahaʻa phosphodiesterase III no kona inotropic maikaʻi, lusitropic a me nā hopena dilating.ʻAʻole like me nā lāʻau cardiotonic ʻē aʻe, hiki i ka levosimendan ke hana i nā hopena inotropic maikaʻi me ka ʻole e hoʻolōʻihi i ka hoʻomaha ʻana o ka myocardial a i ʻole ka hoʻonui ʻana i ka maʻi arrythmias malignant.Ua hōʻike ʻia ma ke ʻano he haʻahaʻa haʻahaʻa o ka make i nā maʻi me ka puʻuwai puʻuwai ke hoʻohālikelike ʻia me ka placebo a me ka dobutamine.No ka mea he ʻoi aku ka nui o kona hiki, aia ʻo levosimendan i kēia manawa ma lalo o ka loiloi lapaʻau hou ma ke ʻano he lapaʻau maʻamau no ka hāʻule ʻana o ka naʻau congestive.